AttributesValues
rdf:type
rdfs:seeAlso
Description
  • This subanalysis of the phase 3 VISTA trial aimed to assess the frequency, characteristics and reversibility of, and prognostic factors for, bortezomib-associated peripheral neuropathy (PN) in newly diagnosed patients with multiple myeloma ineligible for high-dose therapy who received bortezomib plus melphalan-prednisone.
  • This subanalysis of the phase 3 VISTA trial aimed to assess the frequency, characteristics and reversibility of, and prognostic factors for, bortezomib-associated peripheral neuropathy (PN) in newly diagnosed patients with multiple myeloma ineligible for high-dose therapy who received bortezomib plus melphalan-prednisone. (en)
Title
  • Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study
  • Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study (en)
skos:prefLabel
  • Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study
  • Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study (en)
skos:notation
  • RIV/00064165:_____/11:10930!RIV12-MZ0-00064165
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • N
http://linked.open...iv/cisloPeriodika
  • 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 227118
http://linked.open...ai/riv/idVysledku
  • RIV/00064165:_____/11:10930
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • VISTA trial; bortezomib; multiple myeloma; high-dose therapy; melphalan-prednisone; peripheral neuropathy (PN) (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • DK - Dánské království
http://linked.open...ontrolniKodProRIV
  • [8D8AAA737CE4]
http://linked.open...i/riv/nazevZdroje
  • European Journal of Haematology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 2011/86
http://linked.open...iv/tvurceVysledku
  • San Miguel, Jesús F.
  • Dimopoulos, Meletios A.
  • Khuageva, Nuriet K.
  • Richardson, Paul G.
  • Schlag, Rudolf
  • Shpilberg, Ofer
  • Špička, Ivan
  • Palumbo, Antonio
  • Cakan, Andrew
  • Deraedt, William
  • Esseltine, Dixie-Lee
  • Kevin, Liu
  • Kropf, Martin
  • Mateos, Maria-Victoria
  • Van de Velde, Helgi
  • Wu, Ka Lung
http://linked.open...ain/vavai/riv/wos
  • 000285302200003
issn
  • 0902-4441
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software